No results for ‘’
Galaxy Surfactants Ltd
NSE: GALAXYSURF BSE: 540935
₹2247.40
(1.81%)
Mon, 14 Sept 2026, 07:46 am
Market Cap (in Cr)8116.48
PE Ratio22.56
Dividend0.96
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
- FAQs
Galaxy Surfactants Analysis
dividend
Pros
- Dividends paid are well covered by earnings (5.8x coverage).
- Dividends after 3 years are expected to be well covered by earnings (4.7x coverage).
- Galaxy Surfactants's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Cons
- Dividend payments have increased, but Galaxy Surfactants only paid a dividend in the past 2 years.
- Galaxy Surfactants has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Galaxy Surfactants's dividend is below the markets top 25% of dividend payers in India (3.08%).
future
Pros
- Galaxy Surfactants's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Galaxy Surfactants's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Galaxy Surfactants is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
- Performance (ROE) is expected to be above the current IN Chemicals industry average.
- Galaxy Surfactants's revenue growth is expected to exceed the India market average.
Cons
- Cash flow for Galaxy Surfactants is expected to decrease over the next 2 years.
- Galaxy Surfactants's earnings are expected to grow by 13.6% yearly, however this is not considered high growth (20% yearly).
- Galaxy Surfactants's earnings growth is positive but not above the India market average.
- Galaxy Surfactants's earnings are expected to increase but not above the low risk growth rate next year.
- Galaxy Surfactants's net income is expected to increase but not above the 50% threshold in 2 years time.
- A decline in Galaxy Surfactants's performance (ROE) is expected over the next 3 years.
- Galaxy Surfactants's revenue is expected to increase but not above the 50% threshold in 2 years time.
- Galaxy Surfactants's revenue is expected to grow by 11.1% yearly, however this is not considered high growth (20% yearly).
health
Pros
- Galaxy Surfactants is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Galaxy Surfactants is profitable, therefore cash runway is not a concern.
- Galaxy Surfactants is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (103.2%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 3.2x debt.
- Galaxy Surfactants's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (121.5% vs 29.1% today).
- Interest payments on debt are well covered by earnings (EBIT is 20.1x coverage).
- Galaxy Surfactants's level of debt (29.1%) compared to net worth is satisfactory (less than 40%).
Cons
- High level of physical assets or inventory.
management
Pros
- The tenure for the Galaxy Surfactants board of directors is about average.
- Unnathan's remuneration is about average for companies of similar size in India.
- Unnathan's compensation has been consistent with company performance over the past year, both up more than 20%.
- The tenure for the Galaxy Surfactants management team is about average.
Cons
- Galaxy Surfactants individual insiders have sold more shares than they have bought in the past 3 months.
past
Pros
- Galaxy Surfactants's 1-year earnings growth exceeds its 5-year average (29.2% vs 18.6%)
- Galaxy Surfactants's year on year earnings growth rate has been positive over the past 5 years.
- Galaxy Surfactants used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Galaxy Surfactants has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Galaxy Surfactants's earnings growth has exceeded the IN Chemicals industry average in the past year (29.2% vs 9.1%).
Cons
- Galaxy Surfactants's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
value
Pros
- GALAXYSURF outperformed the Chemicals industry which returned 2.2% over the past year.
- GALAXYSURF outperformed the Market in India which returned -14.5% over the past year.
Cons
- Galaxy Surfactants's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Galaxy Surfactants's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Galaxy Surfactants is overvalued based on assets compared to the IN Chemicals industry average.
- Galaxy Surfactants is poor value based on expected growth next year.
- Galaxy Surfactants is overvalued based on earnings compared to the IN Chemicals industry average.
- Galaxy Surfactants is overvalued based on earnings compared to the India market.
- NSEI:GALAXYSURF is up 4.3% underperforming the Chemicals industry which returned 6.9% over the past month.
- NSEI:GALAXYSURF is up 4.3% underperforming the market in India which returned 8% over the past month.